Szereday Z, Csernus B, Nagy M, László T, Warnke R A, Matolcsy A
Department of Pathology of the University Medical School of Pécs, Pécs, Hungary.
Am J Pathol. 2000 Mar;156(3):1017-24. doi: 10.1016/S0002-9440(10)64969-3.
Follicular lymphoma (FL) is a B cell non-Hodgkin's lymphoma (NHL) that frequently displays a t(14;18) translocation. Clonal evolution and histological transformation of FL is frequently associated with the accumulation of secondary genetic alterations. It has been demonstrated that the BCL-6 gene can be altered by chromosomal rearrangements and by mutations clustering in its 5' noncoding region in a significant fraction of FL and diffuse large cell lymphoma (DLCL). To elucidate the role of the BCL-6 gene alterations in the histological transformation and clonal progression of FL, we analyzed serial biopsy specimens from 12 patients with FL. Two cases of FL showed no histological alteration in the second biopsy, and 10 cases of FL showed morphological transformation to DLCL in the second biopsy. Southern blot analysis was used to detect rearrangement of the BCL-6 gene, polymerase chain reaction-single strand conformation polymorphism and sequence analysis were performed for identification of mutations in the 5' noncoding region of the BCL-6 gene, and immunohistochemical analysis was applied to reveal the BCL-6 protein expression. No BCL-6 gene rearrangement was detected in any of the samples, but a total of 58 mutations were found in the 5' noncoding region of the BCL-6 gene in seven cases. In five cases, both the FL and the clonally related FL or DLCL, and in two cases only the DLCL samples were mutated. The mutations were identical in multiple biopsy specimens of FL that did not show morphological transformation. In six patients where FL cells underwent morphological transformation, considerable intraclonal sequence heterogeneity was observed, indicating an ongoing type of somatic mutation. Based on the pattern of shared and nonshared mutations, the genealogical relationship of neoplastic clones could be established. In all of these cases, the histological transformation of FL was associated with the emergence of a subpopulation marked by new sites of mutations in the BCL-6 5' noncoding sequences. In three of these six cases, the histological transformation is also associated with the reduced expression of the BCL-6 protein. These findings demonstrate that mutation of the 5' noncoding region of the BCL-6 gene developed in the clonal evolution of FL, and at different time points in the lymphoma evolution different clonotypes dominate.
滤泡性淋巴瘤(FL)是一种B细胞非霍奇金淋巴瘤(NHL),常出现t(14;18)易位。FL的克隆进化和组织学转化常与继发性基因改变的积累相关。已证明,在相当一部分FL和弥漫性大细胞淋巴瘤(DLCL)中,BCL-6基因可通过染色体重排以及在其5'非编码区聚集的突变而发生改变。为阐明BCL-6基因改变在FL组织学转化和克隆进展中的作用,我们分析了12例FL患者的系列活检标本。2例FL在第二次活检时未显示组织学改变,10例FL在第二次活检时显示形态学转化为DLCL。采用Southern印迹分析检测BCL-6基因重排,进行聚合酶链反应-单链构象多态性分析和序列分析以鉴定BCL-6基因5'非编码区的突变,并应用免疫组织化学分析揭示BCL-6蛋白表达。所有样本均未检测到BCL-6基因重排,但在7例患者的BCL-6基因5'非编码区共发现58个突变。5例中,FL以及克隆相关的FL或DLCL均发生突变,2例仅DLCL样本发生突变。在未显示形态学转化的FL多个活检标本中,突变是相同的。在6例FL细胞发生形态学转化的患者中,观察到相当程度的克隆内序列异质性,表明存在一种持续的体细胞突变类型。基于共享和非共享突变的模式,可以建立肿瘤克隆的谱系关系。在所有这些病例中,FL的组织学转化与以BCL-6 5'非编码序列新突变位点为特征的亚群出现相关。在这6例中的3例中,组织学转化还与BCL-6蛋白表达降低相关。这些发现表明,BCL-6基因5'非编码区的突变在FL的克隆进化过程中发生,并且在淋巴瘤进化的不同时间点不同的克隆型占主导地位。